Increased accessibility and representation: Incorporating pragmatic features (PFs) in oncology clinical trials can increase accessibility to a broader and more diverse patient population, including ...
Covariate-adaptive randomization represents an advanced methodology in the design of clinical trials, ensuring a balanced distribution of prognostic factors among treatment groups. This approach ...
The integration of artificial intelligence (AI) and machine learning (ML) in oncology clinical trials is rapidly evolving alongside the broader field. For example, AI-driven adaptive trial designs may ...
The COVID Vaccine Derby: A Guide to the Top Contenders When can we expect a COVID vaccine to be ready, and which one will it be? Dr F. Perry Wilson gives a tour of the seven vaccines currently in ...
For more than a decade, patient recruitment and retention have been persistent hurdles in clinical research and are consistently cited as the biggest operational challenges with r ...
Each year, millions of Americans are diagnosed with health conditions, many of which are chronic or even life-threatening, according to the Centers for Disease Control and Prevention. Chances are, ...
When people hear the term “clinical trial,” they often imagine someone with a serious illness, desperate for a last-resort treatment, being poked and prodded in a lab. These images are persistent, but ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results